Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia

Video

The hematologist from UC Health discussed the role of allogeneic stem cell transplant at first remission based on risk stratification.

This content originally appeared on our sister site, OncLive.

Recent Videos
Daniela van Eickels, MD, PhD, MPH, the vice president and head of medical affairs for Bristol Myers Squibb’s Cell Therapy Organization
Paul Melmeyer, MPP, the executive vice president of public policy & advocacy at MDA
Daniela van Eickels, MD, PhD, MPH, the vice president and head of medical affairs for Bristol Myers Squibb’s Cell Therapy Organization
Arun Upadhyay, PhD, the chief scientific officer and head of research, development, and Medical at Ocugen
Arun Upadhyay, PhD, the chief scientific officer and head of research, development, and Medical at Ocugen
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
Barry J. Byrne, MD, PhD, the chief medical advisor of Muscular Dystrophy Association (MDA) and a physician-scientist at the University of Florida
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
Related Content
Molly Borchardt, PharmD

Payer Challenges for Patient Access to Autologous Cell and Gene Therapies

Molly Borchardt, PharmD;Phil Cyr, MPH;Erin Lopata, PharmD, MPH;Jason Foster, MBA
October 23rd 2024
Article

Autologous cell and gene therapies show promise but face barriers such as high costs, limited access, and payer concerns over long-term effectiveness.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – October 18, 2024

CGTLive Staff
October 18th 2024
Article

Review top news and interview highlights from the week ending October 18, 2024.

Around the Helix: Cell and Gene Therapy Company Updates – October 16, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 16, 2024

Noah Stansfield
October 16th 2024
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Hematological Malignancies Detected in Some Patients Treated With bluebird bio’s Active Cerebral Adrenoleukodystrophy Gene Therapy Eli-Cel

Hematological Malignancies Detected in Some Patients Treated With bluebird bio’s Active Cerebral Adrenoleukodystrophy Gene Therapy Eli-Cel

Noah Stansfield
October 15th 2024
Article

Seven of 67 patients treated with eli-cel across multiple clinical trials have developed hematologic malignancies, according to findings published in The New England Journal of Medicine.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – October 11, 2024

CGTLive Staff
October 11th 2024
Article

Review top news and interview highlights from the week ending October 11, 2024.

Kiromic BioPharma’s NSCLC T-cell Therapy Deltacel Continues to Provide Disease Stabilization in Updated Data

Kiromic BioPharma’s NSCLC T-cell Therapy Deltacel Continues to Provide Disease Stabilization in Updated Data

Noah Stansfield
October 10th 2024
Article

Kiromic reported that the fourth patient to have been treated in the trial showed a 5.3% reduction in tumor size with regard to baseline.

© 2024 MJH Life Sciences

All rights reserved.